Skip to main content
Erschienen in: Osteoporosis International 1/2011

01.01.2011 | Original Article

Patterns of treatment in Australian men following fracture

verfasst von: R. Otmar, M. J. Henry, M. A. Kotowicz, G. C. Nicholson, S. Korn, J. A. Pasco

Erschienen in: Osteoporosis International | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Summary

This study aimed to describe treatment initiation rates for men who had recently sustained a fracture. Most (75.9%) men potentially eligible for subsidised treatment at the time of fracture remained untreated even after a subsequent fracture.

Introduction

This study aimed to describe treatment initiation rates for men who had recently sustained a fracture.

Methods

The study was conducted as part of the Geelong Osteoporosis Study in south-eastern Australia. Men in the study area who had sustained an incident fracture in the period July 2006 to December 2007 were identified from hospital radiology reports. A self-report questionnaire was sent to eligible participants approximately 12 months after fracture. Respondents were asked for details of medications prescribed for ‘osteoporosis/fracture/low bone mass’ before and after fracture, and where applicable, reasons for cessation of treatment. We analysed the results for 109 men aged 50 years and older who had sustained fracture in the study period.

Results

Most (75.9%) men potentially eligible for subsidised treatment at the time of fracture remained untreated. Of the 87 men who were untreated, nine had osteoporosis at the hip and/or spine and 29 (26.6%) reported having sustained a low trauma prior fracture.

Conclusions

Our findings are consistent with previously published data showing low rates of treatment initiation in men eligible for osteoporosis treatment. There appear to be barriers involving participants’ and medical practitioners’ knowledge, beliefs and attitudes regarding osteoporosis and treatment, as well as in the doctor–patient partnership in osteoporosis management. Establishment of clinical pathways for fracture management beyond orthopaedic care may be one of a range of appropriate responses.
Literatur
1.
Zurück zum Zitat Seeman E, Eisman JA (2004) Treatment of osteoporosis: why, whom, when and how to treat. Med J Aust 180:298–303PubMed Seeman E, Eisman JA (2004) Treatment of osteoporosis: why, whom, when and how to treat. Med J Aust 180:298–303PubMed
2.
Zurück zum Zitat Pasco JA, Sanders KM, Hoekstra FM, Henry MJ, Nicholson GC, Kotowicz MA (2005) The human cost of fracture. Osteoporos Int 16:2046–2052CrossRefPubMed Pasco JA, Sanders KM, Hoekstra FM, Henry MJ, Nicholson GC, Kotowicz MA (2005) The human cost of fracture. Osteoporos Int 16:2046–2052CrossRefPubMed
3.
Zurück zum Zitat Sanders KM, Nicholson GC, Ugoni AM, Pasco JA, Seeman E, Kotowicz MA (1999) Health burden of hip and other fractures in Australia beyond 2000. Med J Aust 170:467–470PubMed Sanders KM, Nicholson GC, Ugoni AM, Pasco JA, Seeman E, Kotowicz MA (1999) Health burden of hip and other fractures in Australia beyond 2000. Med J Aust 170:467–470PubMed
4.
Zurück zum Zitat Smith JA (2007) Beyond masculine stereotypes: moving men's health promotion forward in Australia. Health Promot J Aust 18:20–25 Smith JA (2007) Beyond masculine stereotypes: moving men's health promotion forward in Australia. Health Promot J Aust 18:20–25
6.
Zurück zum Zitat Tuck SP, Datta HK (2007) Osteoporosis in the aging male: treatment options. Clin Interv Aging 2:521–536PubMed Tuck SP, Datta HK (2007) Osteoporosis in the aging male: treatment options. Clin Interv Aging 2:521–536PubMed
7.
Zurück zum Zitat Cheng N, Green ME (2008) Osteoporosis screening for men: are family physicians following the guidelines? Can Fam Physician 54:1140–1145PubMed Cheng N, Green ME (2008) Osteoporosis screening for men: are family physicians following the guidelines? Can Fam Physician 54:1140–1145PubMed
9.
Zurück zum Zitat Seeman E, Bianchi G, Adami S, Kanis J, Khosla S, Orwoll E (2004) Osteoporosis in men—consensus is premature. Calcif Tissue Int 75:120–122PubMed Seeman E, Bianchi G, Adami S, Kanis J, Khosla S, Orwoll E (2004) Osteoporosis in men—consensus is premature. Calcif Tissue Int 75:120–122PubMed
10.
Zurück zum Zitat Seeman E, Bianchi G, Khosla S, Kanis JA, Orwoll E (2006) Bone fragility in men—where are we? Osteoporos Int 17:1577–1583CrossRefPubMed Seeman E, Bianchi G, Khosla S, Kanis JA, Orwoll E (2006) Bone fragility in men—where are we? Osteoporos Int 17:1577–1583CrossRefPubMed
11.
12.
Zurück zum Zitat Kotowicz MA, Sarah B, Pasco JA, Henry MJ, Sanders KM, Korn S, Nicholson GC (2001) Sex bias in referral for bone densitometry. In First Joint Meeting of the International Bone and Mineral Society and the European Calcified Tissue Society. Elsevier, Madrid, p S237 Kotowicz MA, Sarah B, Pasco JA, Henry MJ, Sanders KM, Korn S, Nicholson GC (2001) Sex bias in referral for bone densitometry. In First Joint Meeting of the International Bone and Mineral Society and the European Calcified Tissue Society. Elsevier, Madrid, p S237
13.
Zurück zum Zitat Henry MJ, Pasco JA, Korn S, GIbson J, Kotowicz MA, Nicholson GC (in press) Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int Henry MJ, Pasco JA, Korn S, GIbson J, Kotowicz MA, Nicholson GC (in press) Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int
14.
Zurück zum Zitat Kaufmann JM, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky GP, Lindsay R, Mitlak BH (2005) Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int 16:510–516CrossRef Kaufmann JM, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky GP, Lindsay R, Mitlak BH (2005) Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int 16:510–516CrossRef
15.
Zurück zum Zitat Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610CrossRefPubMed Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610CrossRefPubMed
16.
Zurück zum Zitat Ringe JD, Faber H, Farahmand P, Dorst A (2005) Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int 26(5):427–431CrossRefPubMed Ringe JD, Faber H, Farahmand P, Dorst A (2005) Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int 26(5):427–431CrossRefPubMed
17.
Zurück zum Zitat Finklestein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349(13):1216–1226CrossRef Finklestein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM (2003) The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349(13):1216–1226CrossRef
18.
Zurück zum Zitat Lyles KW, Colón-Emeric CS, Magaziner JS (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRefPubMed Lyles KW, Colón-Emeric CS, Magaziner JS (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRefPubMed
19.
Zurück zum Zitat Lekkerkerker F, Kanis JA, Alsayed N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kaufmann JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY (2007) Adherence to treatment of osteoporosis: a need for study. Osteoporos Int 18:1311–1317CrossRefPubMed Lekkerkerker F, Kanis JA, Alsayed N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kaufmann JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY (2007) Adherence to treatment of osteoporosis: a need for study. Osteoporos Int 18:1311–1317CrossRefPubMed
20.
Zurück zum Zitat Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914–921CrossRefPubMed Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, Adami S (2006) Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int 17:914–921CrossRefPubMed
21.
Zurück zum Zitat Gold DT, Silverman S (2006) Review of adherence to medications for the treatment of osteoporosis. Curr Osteopor Rep 4:21–27CrossRef Gold DT, Silverman S (2006) Review of adherence to medications for the treatment of osteoporosis. Curr Osteopor Rep 4:21–27CrossRef
22.
Zurück zum Zitat Pasco JA, Henry MJ, Gundry TM et al (1999) Identification of incident fractures: the Geelong Osteoporosis Study. Aust N Z J Med 29:203–206PubMed Pasco JA, Henry MJ, Gundry TM et al (1999) Identification of incident fractures: the Geelong Osteoporosis Study. Aust N Z J Med 29:203–206PubMed
23.
Zurück zum Zitat Pasco JA, Henry MJ, Korn S, Nicholson GC, Kotowicz MA (2009) Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men. Osteoporos Int 20(5):787–792CrossRefPubMed Pasco JA, Henry MJ, Korn S, Nicholson GC, Kotowicz MA (2009) Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men. Osteoporos Int 20(5):787–792CrossRefPubMed
24.
Zurück zum Zitat World Medical Association (2008) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects World Medical Association (2008) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects
25.
Zurück zum Zitat Edwards BJ, Bunta AD, Simonelli C, Bolander M, Fitzpatrick LA (2007) Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res 461:226–230PubMed Edwards BJ, Bunta AD, Simonelli C, Bolander M, Fitzpatrick LA (2007) Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res 461:226–230PubMed
26.
Zurück zum Zitat Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD (2007) Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 24:37–55CrossRefPubMed Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD (2007) Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 24:37–55CrossRefPubMed
27.
Zurück zum Zitat Center JR, Nguyen TV, Scheider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 453:878–882CrossRef Center JR, Nguyen TV, Scheider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 453:878–882CrossRef
28.
Zurück zum Zitat Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM (2006) Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Jt Surg Am 88-A:25–34CrossRef Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM (2006) Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Jt Surg Am 88-A:25–34CrossRef
29.
Zurück zum Zitat Taylor JC, Sterkel B, Utley M, Shipley M, Newman S, Horton M, Fitz-Clarence H (2001) Opinions and experiences in general practice on osteoporosis prevention, diagnosis and management. Osteoporos Int 12:844–848CrossRefPubMed Taylor JC, Sterkel B, Utley M, Shipley M, Newman S, Horton M, Fitz-Clarence H (2001) Opinions and experiences in general practice on osteoporosis prevention, diagnosis and management. Osteoporos Int 12:844–848CrossRefPubMed
30.
Zurück zum Zitat Elliott RA, Ross-Degnan D, Adams AS, Safran DG, Soumerai SB (2007) Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. Soc Gen Intern Med 461:805–810CrossRef Elliott RA, Ross-Degnan D, Adams AS, Safran DG, Soumerai SB (2007) Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. Soc Gen Intern Med 461:805–810CrossRef
Metadaten
Titel
Patterns of treatment in Australian men following fracture
verfasst von
R. Otmar
M. J. Henry
M. A. Kotowicz
G. C. Nicholson
S. Korn
J. A. Pasco
Publikationsdatum
01.01.2011
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 1/2011
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-010-1204-7

Weitere Artikel der Ausgabe 1/2011

Osteoporosis International 1/2011 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.